| 18S rRNA | 18S ribosomal RNA |
| 3-HAA | 3-hydroxyanthranilic acid |
| 3-HAO | 3-hydroxyanthranilate 3,4-dioxygenase |
| 3HK | 3-hydroxy-kynurenine |
| AA | anthranilic acid |
| ACMSD | aminocarboxymuconate semialdehyde decarboxylase |
| AADAT | kynurenine/alpha-aminoadipate aminotransferase |
| CI | confidence interval |
| CNS | central nervous system |
| CRP | C-reactive protein |
| CSF | cerebrospinal fluid |
| DM | diabetes mellitus |
| DtN | door-to-needle (time) |
| HT | hypertension |
| HL | hyperlipidaemia |
| IDO1 | indoleamine 2,3-dioxygenase 1 |
| KAT | kynurenine aminotransferase |
| KMO | kynurenine monooxygenase |
| KYAT1 | kynurenine aminotransferase 1 |
| KYN | kynurenine |
| KYNA | kynurenic acid |
| KYNU | kynureninase |
| KP | kynurenine pathway |
| LD | linkage disequilibrium |
| LDL | low density lipoprotein |
| mRS | modified Rankin Scale |
| NIHSS | National Institutes of Health Stroke Scale |
| OR | odds ratio |
| PBS | peripheral blood sample |
| RT-qPCR | reverse transcription-qPCR |
| QA | quinolinic acid |
| qPCR | quantitative polymerase chain reaction |
| SNP | single nucleotide polymorphism |
| TDO2 | tryptophan 2,3-dioxygenase |
| TOAST | Trial of Org 10172 in Acute Stroke Treatment |
| TPH1 | tryptophan hydroxylase 1 |
| TPH2 | tryptophan hydroxylase 2 |
| UN | urea nitrogen |
| WBC | white blood cell |